Skip to Content

ENA 100 (Idhifa 100 mg)

Generic Name: enasidenib

Pill with imprint ENA 100 is Yellow, Capsule-shape and has been identified as Idhifa 100 mg. It is supplied by Celgene Corporation.

Idhifa is used in the treatment of acute myeloid leukemia and belongs to the drug class miscellaneous antineoplastics.

Images for ENA 100

Idhifa 100 mg ENA 100

Idhifa

Generic Name:: enasidenib
Imprint:: ENA 100
Strength:: 100 mg
Color:: Yellow
Shape:: Capsule-shape
Availability:: Prescription only
Drug Class:: Miscellaneous antineoplastics
CSA Schedule:: Unknown
Labeler / Supplier:: Celgene Corporation
National Drug Code (NDC):: 59572-0710

More Info Imprint Search Print

Get help with Imprint Code FAQs.

More about Idhifa (enasidenib)

Consumer resources

Professional resources

Related treatment guides

Acute Myeloid Leukemia

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Oct 1st, 2018), Cerner Multum™ (updated Oct 2nd, 2018), Wolters Kluwer™ (updated Oct 2nd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.